La vendita allo scoperto per icad dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di icad. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

icad (NASDAQ:ICAD) Azioni, Report sulle vendite allo scoperto

icad

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

icad Inc

Icade

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Keybanc analyst Jackson Ader downgraded the rating for Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) from Overweight to Sector Weight. Microsoft shares closed at $371.61 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Laidlaw &amp; Co. analyst Yale Jen downgraded iCAD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) from Buy to Hold. iCAD shares closed at $3.07 on Wednesday. <a href="https://www.benzinga.com/quote/ICAD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Steve Barger downgraded Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) from Overweight to Sector Weight. Amkor Tech shares closed at $16.15 on Wednesday. <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Evan David Seigerman downgraded Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) from Outperform to Market Perform and lowered the price target from $105 to $64. Novo Nordisk shares closed at $62.88 on Wednesday. <a href="https://www.benzinga.com/quote/NVO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Steve Barger downgraded the rating for Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) from Overweight to Sector Weight. Teradyne shares closed at $71.16 on Wednesday.  <a href="https://www.benzinga.com/quote/TER/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying MSFT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="622" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17073357/image-1-8-1024x622.png" alt="" class="wp-image-876378" style="width:520px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17073357/image-1-8-1024x622.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17073357/image-1-8-300x182.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17073357/image-1-8-768x466.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17073357/image-1-8.png 1082w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44857276/netflix-unitedhealth-group-and-3-stocks-to-watch-heading-into-thursday">Netflix, UnitedHealth Group And 3 Stocks To Watch Heading Into Thursday</a> </li>
</ul>
Photo via Shutterstock

News

Downgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

AMKR

ICAD

MSFT

This Microsoft Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Laidlaw &amp; Co. analyst Yale Jen downgrades icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) from Buy to Hold.

Laidlaw & Co. Downgrades icad to Hold

<h3>Gainers</h3>
<ul>
<li>icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) stock moved upwards by 73.0% to $3.34 during Wednesday's regular session. The market value of their outstanding shares is at $88.0 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock increased by 26.25% to $4.18. The market value of their outstanding shares is at $63.6 million. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) stock increased by 22.87% to $7.09. The company's market cap stands at $336.0 million. </li>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) shares rose 21.48% to $1.09. The company's market cap stands at $18.0 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares rose 18.94% to $0.69. The company's market cap stands at $22.8 million. </li>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares moved upwards by 18.11% to $2.87. The company's market cap stands at $13.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock declined by 34.4% to $0.13 during Wednesday's regular session. The market value of their outstanding shares is at $1.6 million. </li>
<li>Biomerica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) stock fell 26.31% to $0.42. The market value of their outstanding shares is at $7.7 million. The company's, Q3 earnings came out 2 days ago. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock decreased by 19.52% to $1.37. The company's market cap stands at $18.8 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSPR#NASDAQ">MSPR</a>) shares declined by 19.05% to $1.87. The market value of their outstanding shares is at $3.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>Acrivon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRV#NASDAQ">ACRV</a>) shares declined by 17.24% to $1.78. The company's market cap stands at $55.4 million. </li>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) shares fell 15.84% to $0.01. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ACRV

BMRA

JUNS

LGMK

MIRA

MSPR

PHIO

SXTC

SYRA

ZYBT

12 Health Care Stocks Moving In Wednesday's Intraday Session

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 200 points on Wednesday.
The Dow traded down 0.55% to 40,145.06 while the NASDAQ dipped 2.08% to 16,473.81. The S&amp;P 500 also fell, dropping, 1.22% to 5,330.57.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44836659/top-3-industrials-stocks-that-may-plunge-this-month">Top 3 Industrials Stocks That May Plunge This Month</a>
Leading and Lagging Sectors Energy shares surged by 1.9% on Wednesday.
In trading on Wednesday, information technology shares fell by 2.8%.
Top Headline
Travelers Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) posted better-than-expected first-quarter results on Wednesday.
The company posted quarterly sales of $11.81 billion (+5% year over year) outpacing the analyst consensus estimate of $10.81 billion. The company reported first-quarter adjusted EPS of $1.91, beating the street view of $0.80.
The company declared a regular quarterly dividend increase of 5% to $1.10 per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares shot up 67% to $3.2150 after the company announced that it has secured an exclusive partnership with Mezzofy to become the sole distributor of its digital coupon platform and is targeting $2-4 million in annual recurring revenue.</li>
<li>Shares of Hertz Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>)got a boost, surging 15% to $4.2106 after Pershing Square Capital Management disclosed via a 13F that it bought 12.7 million shares in the company.</li>
<li>iCAD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) shares were also up, gaining 67% to $3.2150 after the company announced it will be acquired by RadNet for a deal worth approximately $103 million.</li>
</ul>
Equities Trading DOWN
<ul>
<li>SUNation Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) shares dropped 48% to $0.0211 as the company announced a 1-for-200 reverse stock split.</li>
<li>Shares of Ostin Technology Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) were down 38% to $1.98. Ostin Technology Group announced the pricing of $5.0 million registered direct offering.</li>
<li>Biomerica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) was down, falling 26% to $0.4243 after the company announced a 1-for-8 reverse stock split.</li>
</ul>
Commodities In commodity news, oil traded up 1.7% to $62.39 while gold traded up 2.8% at $3,330.10.
Silver traded up 1.6% to $32.805 on Wednesday, while copper rose 0.1% to $4.6315.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.83%, Germany's DAX 40 declined 0.51% and France's CAC 40 dipped 0.67%. Spain's IBEX 35 Index slipped 0.12%, while London's FTSE 100 fell 0.26%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 1.01%, China's Shanghai Composite gaining 0.26%, Hong Kong's Gang Seng index dipping 1.91% and India's BSE Sensex gaining 0.4%.
Economics
<ul>
<li>U.S. industrial production declined by 0.3% in March compared to market estimates of a 0.2% fall.</li>
<li>U.S. retail sales rose 1.4% month-over-month in March versus a 0.2% gain in the previous month and better than estimates of 1.3%.</li>
<li>U.S. mortgage application volumes dipped by 8.5% from the previous week during the second week of April.</li>
<li>Crude oil inventories in the U.S. climbed by 0.515 million barrels in the week ended April 11, compared to market estimates of a 0.4 million gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44838854/nvidia-to-160-here-are-10-top-analyst-forecasts-for-wednesday">Nvidia To $160? Here Are 10 Top Analyst Forecasts For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

SUNE

Crude Oil Moves Higher; Travelers Earnings Beat Estimates

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 2% on Wednesday.
The Dow traded down 0.67% to 40,099.73 while the NASDAQ dipped 2.12% to 16,466.96. The S&amp;P 500 also fell, dropping, 1.27% to 5,327.95.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44836659/top-3-industrials-stocks-that-may-plunge-this-month">Top 3 Industrials Stocks That May Plunge This Month</a>
Leading and Lagging Sectors Energy shares surged by 1.4% on Wednesday.
In trading on Wednesday, information technology shares fell by 3%.
Top Headline
Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) reported better-than-expected first-quarter adjusted EPS results.
Abbott Laboratories reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. The U.S. MedTech giant reported adjusted EPS of $1.09, beating the consensus of $1.07 and the management guidance of $1.05-$1.09.
Abbott Laboratories expects second quarter 2025 adjusted EPS of $1.23-$1.27 versus consensus of $1.25.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares shot up 70% to $3.54 after the company announced that it has secured an exclusive partnership with Mezzofy to become the sole distributor of its digital coupon platform and is targeting $2-4 million in annual recurring revenue.</li>
<li>Shares of Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>)got a boost, surging 70% to $2.3097.</li>
<li>iCAD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) shares were also up, gaining 67% to $3.22 after the company announced it will be acquired by RadNet for a deal worth approximately $103 million.</li>
</ul>
Equities Trading DOWN
<ul>
<li>SUNation Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) shares dropped 40% to $0.0249 as the company announced a 1-for-200 reverse stock split.</li>
<li>Shares of Ostin Technology Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) were down 35% to $2.07. Ostin Technology Group announced the pricing of $5.0 million registered direct offering.</li>
<li>Biomerica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) was down, falling 30% to $0.4006 after the company announced a 1-for-8 reverse stock split.</li>
</ul>
Commodities In commodity news, oil traded up 1.6% to $62.33 while gold traded up 2.6% at $3,323.10.
Silver traded up 1.7% to $32.860 on Wednesday, while copper rose 0.1% to $4.6310.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.7%, Germany's DAX 40 declined 0.4% and France's CAC 40 dipped 0.6%. Spain's IBEX 35 Index slipped 0.1%, while London's FTSE 100 fell 0.3%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 1.01%, China's Shanghai Composite gaining 0.26%, Hong Kong's Gang Seng index dipping 1.91% and India's BSE Sensex gaining 0.4%.
Economics
<ul>
<li>U.S. industrial production declined by 0.3% in March compared to market estimates of a 0.2% fall.</li>
<li>U.S. retail sales rose 1.4% month-over-month in March versus a 0.2% gain in the previous month and better than estimates of 1.3%.</li>
<li>U.S. mortgage application volumes dipped by 8.5% from the previous week during the second week of April.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44838854/nvidia-to-160-here-are-10-top-analyst-forecasts-for-wednesday">Nvidia To $160? Here Are 10 Top Analyst Forecasts For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings

WIIM

iCAD shares are trading higher after the company announced it will be acquired by RadNet for a deal worth approximately $103 million.

<h3>Gainers</h3>
<ul>
<li>icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) shares increased by 72.0% to $3.32 during Wednesday's pre-market session. The company's market cap stands at $87.4 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock increased by 17.82% to $3.9. The market value of their outstanding shares is at $59.3 million. </li>
<li>Renovaro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENB#NASDAQ">RENB</a>) stock rose 12.39% to $0.42. The market value of their outstanding shares is at $66.6 million. </li>
<li>Assembly Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASMB#NASDAQ">ASMB</a>) shares increased by 10.09% to $10.8. The market value of their outstanding shares is at $81.0 million. </li>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) shares moved upwards by 9.06% to $0.98. The company's market cap stands at $16.2 million. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock rose 8.81% to $1.85. The company's market cap stands at $25.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Forian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORA#NASDAQ">FORA</a>) stock declined by 61.1% to $0.81 during Wednesday's pre-market session. The company's market cap stands at $25.2 million. </li>
<li>BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares declined by 15.13% to $1.74. The company's market cap stands at $7.9 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock decreased by 14.56% to $0.17. The market value of their outstanding shares is at $2.0 million. </li>
<li>Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) stock fell 13.44% to $6.7. The company's market cap stands at $988.7 million. </li>
<li>Century Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) stock decreased by 11.18% to $0.45. The market value of their outstanding shares is at $38.2 million. </li>
<li>Aptorum Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) shares declined by 11.03% to $0.96. The market value of their outstanding shares is at $6.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADPT

ASMB

BCDA

FORA

IPSC

RENB

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

U.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of major benchmark indices were lower in premarket.
The Donald Trump administration levied a<a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle"> 245% tariff on China</a> late Tuesday. &#8220;China now faces up to a 245% tariff on imports to the United States as a result of its retaliatory actions,&#8221; stated a White House fact sheet.
Meanwhile, the new U.S. export restrictions halting the shipments of Nvidia Corp.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)<a href="https://benzinga.com/25/04/44830406/nvidia-to-take-55-billion-hit-over-china-chip-export-restrictions-but-top-analyst-dan-ives-says-hes-not-overly-concerned-all-part-of-the-high-game-of-poker"> H20 graphics processing units to China</a> were announced. The announcement comes after the U.S. government informed the company on April 9 that it would now require a license to export those chips.
The 10-year Treasury bond yielded 4.31% and the two-year bond was at 3.81%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool&#8217;s </a>projections show markets pricing a 79.9% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.07%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.44%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-1.08%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.35%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Wednesday. The SPY was down 0.67% to $534.02, while the QQQ declined 1.27% to $452.17, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Weighing on U.S. stocks Tuesday, the consumer discretionary, health care, and consumer staples sectors saw the biggest declines.
Bucking the trend, however, information technology and real estate stocks closed higher.
The market moves came as Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) and Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) reported better-than-expected first-quarter earnings, while economic data showed a rise in the NY Empire State Manufacturing Index and flat export prices alongside a slight drop in import prices for March.
The Dow closed Tuesday 10.44% below its 52-week peak of 45,073.63. The S&amp;P 500 ended 12.21% off its 6,147.43 high, and the Nasdaq 100 was 15.27% below its 22,222.61 record.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.049%</td>
<td>16,823.17</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.17%</td>
<td>5,396.63</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.38%</td>
<td>40,368.96</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.11%</td>
<td>1,882.92</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to Mona Mahajan of Edward Jones, the stock valuations were not stretched anymore. &#8220;While market returns have been negative this year, the upside is that valuations are now looking more compelling and are no longer stretched, which was a concern coming into this year.&#8221;
She highlighted that all major indexes were trading at or below their 10-year historical forward price-to-earnings multiples, potentially setting the stage for improved long-term returns.
The S&amp;P 500 forward multiple was around 18 times next year&#8217;s earnings forecast, down from a recent high of 22.7 times, while the Nasdaq forward multiple was about 21 times, down from its recent high of 30 times.
&#8220;In our view, the spike in volatility, a reset in valuations, and signs that the worst-case scenario in the trade war appears to be averted suggest that stocks may find some support and try to carve out a bottom. Risks have risen, but a recession is not inevitable in our view, and stocks appear to have already priced in a significant degree of bad outcomes,&#8221; she added.
Jason Goepfert of White Oak Consultancy LLC noted a historical pattern: whenever the VIX fear index drops from above 50 to the 30 level, the S&amp;P 500 has historically achieved 100% positive gains by year-end.
However, he points out that in the most recent such cycle in May 2020, the S&amp;P 500&#8217;s return after a year was 42.96%. Goepfert&#8217;s analysis of similar cycles in 2009, 2002, and 1988 also reveals a short-term median loss of 0.7% for the S&amp;P 500 in the week following the VIX&#8217;s drop to 30.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The VIX cycle from &gt; 50 to &lt; 30 is on track to trigger today. A bear killer. <a href="https://t.co/rzvdiBw37G">pic.twitter.com/rzvdiBw37G</a>
&mdash; Jason Goepfert (@jasongoepfert) <a href="https://twitter.com/jasongoepfert/status/1912145727448363174?ref_src=twsrc%5Etfw">April 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
According to an X post by Charlie Bilello of Creative Planning, historical data since 1990 showed that the S&amp;P 500 has delivered an average return of 35% in the year following a VIX close above 50, and 129% over the subsequent five years.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/search?q=%24VIX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$VIX</a> closed above 50 last week for the first time since April 2020. In the past, what has that meant for stocks going forward? Video discussion: <a href="https://t.co/YYVlqL4IlH">https://t.co/YYVlqL4IlH</a> <a href="https://t.co/iEy9Wb5myJ">pic.twitter.com/iEy9Wb5myJ</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1912220992963035233?ref_src=twsrc%5Etfw">April 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Wednesday:
<ul>
<li>March&#8217;s U.S. retail sales will be out by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>Industrial production and capacity utilization data for March will be announced at 9:15 a.m. ET.</li>
</ul>
<ul>
<li>Business inventories for February and the home builder confidence index for April will be out by 10:00 a.m. ET.</li>
</ul>
<ul>
<li>Cleveland Fed President Beth Hammack will speak at noon.</li>
</ul>
Stocks In Focus:
<ul>
<li>Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) rose 0.74% in premarket on Wednesday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $1.07 per share on revenue of $10.40 billion.</li>
</ul>
<ul>
<li>Travelers Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) was up 0.076% as Wall Street expects it to report earnings of 80 cents per share on revenue of $10.82 billion before the opening bell.</li>
</ul>
<ul>
<li>Progressive Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) fell 0.01% as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $4.81 per share on revenue of $21.63 billion.</li>
</ul>
<ul>
<li>ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) dropped 4.2% despite beating earnings estimates as its revenue and EPS fell on a sequential basis.</li>
</ul>
<ul>
<li>J B Hunt Transport Services Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) dropped 6.28% after reporting a 7.6% decline in profit for the first quarter. The company posted quarterly revenue of $2.92 billion, compared to market estimates of $2.90 billion.</li>
</ul>
<ul>
<li>iCAD Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) surged 72.02% and Radnet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDNT#NASDAQ">RDNT</a>) fell 2.03% after they announced a definitive all-stock merger agreement where RadNet will acquire iCAD.</li>
</ul>
<ul>
<li>La Rosa Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) jumped 119.16% after Nasdaq granted a 180-day extension, until October 6, 2025, to regain the $1.00 minimum bid price for continued listing under &#8216;LRHC&#8217;.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.60% to hover around $61.70 per barrel.
Gold Spot US Dollar advanced 2.38% to hover around $3,304.35 per ounce. Its fresh record high stood at $3,318 per ounce. The U.S. Dollar Index spot was lower by 0.51% at the 99.7040 level.
Asian markets declined on Wednesday, except India's S&amp;P BSE Sensex, China&#8217;s CSI 300 index. Hong Kong's Hang Seng, Japan's Nikkei 225, Australia's ASX 200, and South Korea's Kospi index ended lower. European markets were also mostly lower in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">Trump Administration Imposes Up To 245% Tariff On Chinese Imports Amid Intensifying Trade Battle</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Futures

Treasuries

Economics

Federal Reserve

ASML

JBHT

LRHC

NVDA

RDNT

US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert

Shares of United Airlines Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) rose sharply in today's pre-market trading <a href="https://www.benzinga.com/general/travel/25/04/44826858/united-airlines-stock-takes-off-on-q1-earnings-strong-q2-forecast-fy-guidance-for-stable-and-recessionary-environments-impossible-to-predict">following first-quarter results.</a>
The company reported adjusted first-quarter earnings of 91 cents per share, beating estimates of 76 cents per share, according to Benzinga Pro. United Airlines reported first-quarter revenue of $13.21 billion, versus analyst estimates of $13.25 billion.
United also provided two sets of guidance for full-year 2025. The company anticipates full-year 2025 adjusted earnings of $11.50 to $13.50 per share in a "stable environment." United expects full-year earnings of $7 to $9 per share in a "recessionary environment."
United Airlines shares jumped 6.1% to $71.06 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>La Rosa Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) rose 101.2% to $0.4064 in pre-market trading.</li>
<li>iCAD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) surged 73.1% to $3.34 in pre-market trading after gaining 6% on Tuesday.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) gained 55.2% to $3.23 in pre-market.</li>
<li>Odyssey Marine Exploration, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) rose 40.6% to $0.5941 in pre-market trading after jumping over 6% on Tuesday.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) jumped 30.2% to $0.3359 in pre-market trading after jumping around 9% on Tuesday.</li>
<li>Electra Battery Materials Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELBM#NASDAQ">ELBM</a>) surged 20.4% to $1.30 in pre-market trading.</li>
<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) gained 12.3% to $155.00 in pre-market trading after the company announced a strategic alliance with AIKYA to launch ESG reporting platform, diginexESG, in Malaysia.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) rose 9.3% to $2.00 in pre-market trading after dipping 11% on Tuesday.</li>
<li>Select Medical Holdings Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEM#NYSE">SEM</a>) gained 9.1% to $17.79 in pre-market trading. Select Medical Holdings will release the financial results for its first quarter on Thursday, May 1, after the closing bell.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aura Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) fell 39% to $3.40 in pre-market trading. Aura Biosciences announced appointment of Teresa Bitetti to Board of Directors.</li>
<li>Ostin Technology Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) fell 30.6% to $2.21 in pre-market trading after the company announced the pricing of $5.0 million registered direct offering.</li>
<li>TruGolf Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) shares fell 27.3% to $0.28 in pre-market trading.</li>
<li>Target Hospitality Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) shares dipped 25.7% to $5.00 in pre-market trading.</li>
<li>Potbelly Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBPB#NASDAQ">PBPB</a>) shares tumbled 25.6% to $6.00 in pre-market trading.</li>
<li>Aardvark Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AARD#NASDAQ">AARD</a>) shares fell 24.4% to $6.00 in pre-market trading after gaining 4% on Tuesday.</li>
<li>Alpha Teknova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) fell 24.4% to $4.40 in today's pre-market trading after gaining 3% on Tuesday.</li>
<li>Hillman Solutions Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLMN#NASDAQ">HLMN</a>) fell 24.2% to $6.00 in pre-market trading. Hillman Solutions will host a conference call to discuss its results for the thirteen weeks ended March 29 on Tuesday, April 29.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) dipped 6% to $127.00 in pre-market trading after the company reported a 7.6% decline in profit for the first quarter. The company posted quarterly revenue of $2.92 billion, compared to market estimates of $2.90 billion.</li>
<li>ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) declined 4.5% to $652.68 in pre-market trading as the company posted first-quarter total net sales of €7.7 billion and net income of €2.4 billion. The company said it sees second-quarter total net sales between €7.2 billion and €7.7 billion.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44811698/jim-cramer-planet-fitness-is-doing-better-than-expected-says-no-to-this-industrial-stock"> Jim Cramer: Planet Fitness Is Doing Better Than Expected, Says No To This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

AARD

AURA

BLMZ

DGNX

ELBM

HLMN

OMEX

PBPB

STBX

TKNO

TRUG

Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) stock moved upwards by 72.5% to $3.33 during Tuesday's after-market session. The company's market cap stands at $87.7 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares increased by 17.69% to $0.69. The company's market cap stands at $16.5 million. </li>
<li>Dogwood Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) stock rose 10.57% to $4.6. The company's market cap stands at $8.7 million. </li>
<li>Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) shares rose 10.0% to $1.1. The market value of their outstanding shares is at $18.3 million. </li>
<li>MetaVia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTVA#NASDAQ">MTVA</a>) shares moved upwards by 9.38% to $0.89. The company's market cap stands at $7.6 million. </li>
<li>Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) shares increased by 8.41% to $0.47. The market value of their outstanding shares is at $106.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares decreased by 9.8% to $0.46 during Tuesday's after-market session. The company's market cap stands at $5.2 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares declined by 8.35% to $0.37. The company's market cap stands at $1.7 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) stock fell 7.87% to $0.42. The market value of their outstanding shares is at $10.6 million. </li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) stock decreased by 6.96% to $0.67. The market value of their outstanding shares is at $1.1 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) shares declined by 6.89% to $0.19. The company's market cap stands at $2.2 million. </li>
<li>Cue Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) shares declined by 6.25% to $0.74. The market value of their outstanding shares is at $46.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

DWTX

ENTO

IRIX

LCTX

MTVA

SLRX

SNSE

12 Health Care Stocks Moving In Tuesday's After-Market Session

iCAD shares are trading higher after the company announced it will be acquired by RadNet for a transaction value of approximately $103 million.

<ul>
<li>The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer</li>
<li>The transaction is expected to add to RadNet's wholly owned subsidiary, DeepHealth, an installed base of over 1,500 healthcare provider locations across over 50 countries</li>
<li>With iCAD's seasoned commercial and engineering team anticipated to join DeepHealth, the combination is expected to accelerate RadNet's growth and leadership in cancer screening and artificial intelligence</li>
<li>Following the completion of the acquisition, iCAD will be integrated into RadNet's DeepHealth portfolio of solutions</li>
<li>RadNet will host a conference call and webcast at 10:30 a.m. ET tomorrow, April 16, 2025, to discuss the transaction &nbsp;</li>
</ul>
LOS ANGELES and NASHUA, N.H., April 15, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDNT#NASDAQ">RDNT</a>) ("RadNet"), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) ("iCAD"), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they have entered into a definitive merger agreement under which RadNet will acquire iCAD in an all stock transaction.
Under the terms of the merger agreement, iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger.
Based upon RadNet's closing price on Monday, April 14, 2025, this represents a transaction value of approximately $103 million, or approximately $3.61 per share of iCAD common stock on a fully diluted basis and an approximately 98% premium to iCAD stockholders based on iCAD's closing stock price on Monday, April 14, 2025.

RadNet To Acquire iCAD; Under The Terms Of The Merger Agreement, iCAD Stockholders Will Receive 0.0677 Shares Of RadNet Common Stock For Each Share Of iCAD Common Stock; This Represents A Transaction Value Of ~$103M, Or $3.61/Share

icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $5.408 million which beat the analyst consensus estimate of $4.827 million by 12.02 percent. This is a 14.07 percent increase over sales of $4.741 million the same period last year.

Earnings Beats

icad Q4 2024 Adj. EPS $(0.03) Beats $(0.05) Estimate, Sales $5.408M Beat $4.827M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Corporacion America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAAP#NYSE">CAAP</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $373.00 million. 
• Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) is likely to report quarterly earnings at $1.19 per share on revenue of $674.52 million. 
• Sportradar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $294.60 million. 
• GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) is estimated to report quarterly loss at $0.27 per share on revenue of $430.70 million. 
• MediWound (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) is estimated to report quarterly loss at $0.61 per share on revenue of $5.75 million. 
• Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) is expected to report quarterly earnings at $6.25 per share on revenue of $2.33 billion. 
• J.Jill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JILL#NYSE">JILL</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $142.33 million. 
• Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $4.60 million. 
• Kingsoft Cloud Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) is projected to report quarterly loss at $0.11 per share on revenue of $269.59 million. 
• American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is estimated to report earnings for its fourth quarter. 
• Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $747.94 million. 
• Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) is projected to report quarterly earnings at $2.93 per share on revenue of $2.35 billion. 
• General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) is projected to report quarterly earnings at $0.96 per share on revenue of $4.96 billion. 
• One Stop Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSS#NASDAQ">OSS</a>) is likely to report quarterly earnings at $0.01 per share on revenue of $15.00 million. 
• Direxion Daily CSI China Internet Index Bull 2X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEB#NYSE">CWEB</a>) is estimated to report earnings for its fourth quarter. 
• HUTCHMED (China) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) is expected to report earnings for its Fiscal Year 2024. 
<h3>Companies Reporting After The Bell</h3>
• Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) is projected to report quarterly earnings at $3.38 per share on revenue of $1.38 billion. 
• Epsilon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSN#NASDAQ">EPSN</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $7.22 million. 
• Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) is likely to report earnings for its fourth quarter. 
• TWFG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWFG#NASDAQ">TWFG</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $47.78 million. 
• Precigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $1.30 million. 
• SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) is expected to report quarterly earnings at $1.01 per share on revenue of $9.70 million. 
• scPharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPH#NASDAQ">SCPH</a>) is projected to report quarterly loss at $0.39 per share on revenue of $12.18 million. 
• CVD Equipment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVV#NASDAQ">CVV</a>) is likely to report earnings for its fourth quarter. 
• Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $8.89 million. 
• JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) is estimated to report quarterly earnings at $1.02 per share on revenue of $559.67 million. 
• Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) is estimated to report quarterly loss at $0.41 per share on revenue of $3.88 million. 
• icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $4.50 million. 
• Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $9.87 million. 
• Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) is projected to report quarterly loss at $0.24 per share on revenue of $15 thousand. 
• LENZ Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) is estimated to report earnings for its fourth quarter. 
• North American (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOA#NYSE">NOA</a>) is estimated to report quarterly earnings at $1.17 per share on revenue of $318.60 million. 
• Aeva Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) is likely to report quarterly loss at $0.58 per share on revenue of $2.47 million. 
• Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) is estimated to report quarterly earnings at $0.67 per share on revenue of $732.00 million. 
• Prudential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) is expected to report earnings for its Fiscal Year 2024. 
• Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $4.94 million. 
• FrontView REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVR#NYSE">FVR</a>) is expected to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEVA

CAAP

CAPR

CWEB

EPSN

FIVE

GROY

JILL

LENZ

LQDA

MDWD

OLLI

PGEN

PRSO

SCPH

SERA

SRAD

SWKH

TISI

TWFG

Earnings Scheduled For March 19, 2025

Contracts

iCAD Enters Into Strategic Reseller Partnership To Deliver a Comprehensive, Multi-Modality AI Suite For Breast Cancer Detection.

<h3>Gainers</h3>
<ul>
<li>GH Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHRS#NASDAQ">GHRS</a>) shares rose 27.4% to $13.5 during Monday's pre-market session. The market value of their outstanding shares is at $702.3 million. </li>
<li>HCW Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) shares rose 25.08% to $0.35. The market value of their outstanding shares is at $15.5 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares moved upwards by 23.0% to $0.44. The market value of their outstanding shares is at $52.6 million. </li>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) shares moved upwards by 21.95% to $0.32. The market value of their outstanding shares is at $9.7 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares moved upwards by 15.06% to $0.47. The company's market cap stands at $4.0 million. </li>
<li>Cutera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ">CUTR</a>) stock rose 14.29% to $0.49. The company's market cap stands at $9.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Viracta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) shares fell 45.3% to $0.08 during Monday's pre-market session. The market value of their outstanding shares is at $3.2 million. </li>
<li>AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) shares fell 16.29% to $4.01. The company's market cap stands at $232.1 million. </li>
<li>Annovis Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) shares decreased by 14.79% to $4.15. The company's market cap stands at $57.2 million. </li>
<li>icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) stock fell 14.38% to $2.74. The market value of their outstanding shares is at $72.2 million. </li>
<li>Nuvectis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCT#NASDAQ">NVCT</a>) stock fell 13.17% to $5.87. The market value of their outstanding shares is at $113.4 million. </li>
<li>Orchestra BioMed Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBIO#NASDAQ">OBIO</a>) stock fell 12.22% to $4.6. The market value of their outstanding shares is at $173.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

ANVS

CUTR

GHRS

HCWB

IVVD

NVCT

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

PRPH

VIRX

12 Health Care Stocks Moving In Monday's Pre-Market Session

Icad shares are trading higher after the company provided Q4 revenue guidance above estimates.

iCAD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) ("iCAD" or the "Company"), a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported select preliminary, unaudited financial results for the fourth quarter of 2024. Based on preliminary, unaudited financial information, the Company expects total revenue for the fourth quarter of 2024 to be between approximately $5.1 and approximately $5.3 million. Total Annual Recurring Revenue (T-ARR) was approximately $9.8 million, up 11% year-over-year. In the fourth quarter of 2024, the Company closed 106 deals, 19 of which were cloud deals with both new and established customers.

Guidance

ICAD Expects Q4 2024 Revenue Between $5.1M-$5.3M; Total Annual Recurring Revenue Reaches $9.8M, Up 11% YoY; Closed 106 Deals, Including 19 Cloud Deals

iCAD shares are trading higher after the company announced it will present its next-generation AI solutions and a second-read AI partnership with Cascaid Health at the RSNA 2024 Annual Meeting.

<a href="https://www.globenewswire.com/Tracker?data=TwjwrnlfW8Qen5u-zdYndKlr5vcGHoIuWTd0bH48Nh3tPUf8i9YA2cWS9NOEhDzB7CEJy_s4AP5ay5ShFgjuBQ==">iCAD, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5.
Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI-driven breast health solutions.

Biotech

General

iCAD Presents Next-Generation AI Solutions And A Second-Read AI Partnership With Cascaid Health At RSNA 2024

Management

Press Releases

iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer

RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

ICAD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iCad, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA, MESA on Behalf of Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of iCAD, Inc. - ICAD

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA on Behalf of Shareholders

ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of Shareholders

iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft's Precision Imaging Network (PIN)

Comments

icad

Vendite allo scoperto

icad (NASDAQ:ICAD) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO